Health Law Rx Podcast

Episode 3: Government Healthcare Enforcement Priorities, ’25 and Beyond

Akerman Healthcare partners Noam Fischman and Jeremy Burnette join Healthcare Practice Group Chair Robert Slavkin for a discussion on recent healthcare enforcement trends in 2025 and beyond. In this episode, the panel provides an overview of: The current landscape of federal healthcare enforcement, including the formation of new government task forces and the use of AI in fraud detection; Financial incentives driving enforcement actions; The increasing role of whistleblowers and litigation funders; and Heightened scrutiny of sectors such as wound care, biologics, and genetic testing. The episode also covers practical steps healthcare organizations can take to strengthen compliance programs, respond effectively to government investigations, and address individual liability risks for providers and investors in a rapidly evolving regulatory environment.

Episode 2: Health Data Privacy and Use of Online Tracking Technologies - Recent Developments

Akerman Healthcare partners Jordan Cohen and Betsy Hodge discuss recent regulatory guidance and enforcement activity by the U.S. Department of Health and Human Services Office for Civil Rights (OCR) and the Federal Trade Commission (FTC) with respect to healthcare entities’ use of online tracking technologies. In this podcast, Jordan and Betsy provide an overview of: How online tracking technologies work, guidance from OCR and the FTC about how use of online tracking technologies may lead to impermissible disclosures of individuals’ health information, recent enforcement activity by the FTC and OCR, and steps healthcare organizations can take to minimize their risk of regulatory enforcement actions related to use of online tracking technology.

Episode 1: We discuss how the end of the public health emergency will impact the healthcare industry

Akerman’s Healthcare Practice Group shares their insights and perspectives on trends and hot topics affecting the healthcare industry today.